Organization

Zhongnan Hospital

13 clinical trials

Clinical trial
Cadonilimab Plus Anlotinib for Recurrent, Metastasis or Persistent Cervical Cancer
Status: Recruiting, Estimated PCD: 2025-11-30
Clinical trial
The Diagnostic Efficiency of 68Ga-FAPI PET/CT in Malignant Tumors
Status: Recruiting, Estimated PCD: 2024-12-31